Reduced-intensity Therapy for Advanced Oropharyngeal Cancer in Non-smoking Human Papilloma Virus (HPV)-16 Positive Patients
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Cetuximab (Primary)
- Indications Carcinoma; Oropharyngeal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 04 Nov 2019 Status changed from active, no longer recruiting to completed.
- 04 Nov 2019 Status changed from active, no longer recruiting to completed.
- 21 Oct 2019 Planned End Date changed from 1 Sep 2019 to 1 Dec 2019.